Dr. Luc Gt Morris, MD

Dr. Morris practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Morris' NPI, 1144355389, was assigned on February 21, 2007. Dr. Morris graduated from New York University School of Medicine in 2004. Dr. Morris holds New York license 244803.

Dr. Morris' primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Morris' primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center (MSK), Department of Surgery. Dmand AI also links Dr. Morris to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Morris practices. Vendor and product names are available with a free account.

Otolaryngology is Dr. Morris' primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Morris is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Morris is licensed in New York.

Dmand AI lists endoscopic sinus surgery and larynx and vocal cord disease among the conditions Dr. Morris treats.

CMS data shows 147 Medicare services from Dr. Morris across 5 procedure codes in 2024, for 112 Medicare patients. Medicare paid $14,845 for them. Every service was in an office.

CMS counts 112 Medicare patients who saw Dr. Morris in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Morris' median patient age at 69, with 47% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Morris for performance year 2024, reported as part of a group. Dr. Morris accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 282 papers to Dr. Morris, published from 2008 to 2025. 2020 was the busiest year, with 26. The most frequent topics are Head and Neck Neoplasms, Thyroid Neoplasms and Carcinoma, Squamous Cell. Dr. Morris has published most often in JAMA Otolaryngol Head Neck Surg. Dr. Morris' most frequent co-authors are Ian Ganly, MD, PhD, Richard J. Wong, MD and Nadeem Riaz, MD.

Dmand AI links Dr. Morris to 2 clinical trials, 2 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Papillomavirus Infections, Squamous Cell Carcinoma of Head and Neck and Carcinoma, Squamous Cell.

CMS Open Payments shows 11 general payments to Dr. Morris from 6 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 80% of the total. Merck Sharp & Dohme Corporation paid the most, $3,318.

Dmand AI lists 1 award for Dr. Morris.

Dr. Morris graduated from New York University School of Medicine in 2004. Dr. Morris is a member of ACS.

Dr. Morris is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.